Showing posts with label Devices. Show all posts
Showing posts with label Devices. Show all posts

Saturday, July 7, 2012

Research and Markets: Industry Dynamics, Growth, Threats & Opportunities in the Medical Devices Industry - 2012-2013 ...

DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/v87c6v/industry_dynamics) has announced the addition of iCD Research's new report "Industry Dynamics, Growth, Threats & Opportunities in the Medical Devices Industry - 2012-2013 : Survey Intelligence" to their offering.

This report is the result of an extensive survey drawn from ICD Research's exclusive panel of leading medical devices industry executives. It analyzes how business strategies and practices in the medical devices industry are set to change in 2012-13. This report gives you access to the category-level supplier selection criteria, business challenges and investment opportunities for leading purchase decision makers. The report also identifies future growth of buyers and suppliers, M&A and e-procurement. This report not only grants access to the opinions and strategies of business decision makers and competitors, but also examines their actions surrounding business priorities. The report also provides access to information categorized by region, company type and size.

Scope

- The opinions and forward looking statements of 174 industry executives have been captured in our in-depth survey, of which 54% represent Director and C-level respondents.

- The research is based on primary survey research conducted by ICD Research accessing its B2B panels comprised of senior purchase decision makers and leading supplier organizations.

- The geographical scope of the research is global - drawing on the activity and expectations of leading industry players across the Americas, Europe, Asia-Pacific, Africa and Middle East.

- This report covers data and analysis on industry developments.

- Key topics covered include threats and opportunities, economic outlook and business confidence.

- In the report, buyers identify what suppliers need to do to maintain their business and the key actions being taken by industry players to overcome the leading business threats.

- The report examines current practices and provides future expectations for the industry over the next 12-24 months.

- The report provides qualitative analysis of the key industry threats and opportunities.

Reasons To Buy

This report will help you to...

- Drive revenues by understanding future product investment areas and growth regions.

- Better promote your business by aligning your capabilities and business practices with your customer's changing needs.

- Secure stronger customer relationships by understanding the leading business concerns and changing strategies of industry buyers.

- Predict how the industry will grow, consolidate and where it will stagnate.

- Uncover the business outlook, key challenges and opportunities identified by suppliers and buyers.

For more information visit http://www.researchandmarkets.com/research/v87c6v/industry_dynamics

Source: iCD Research


View the original article here

Wednesday, June 13, 2012

Research and Markets: Finland Neurology Devices Investment Opportunities, Analysis and Forecasts to 2018

DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/j6vkjm/finland_neurology) has announced the addition of Global Markets Direct's new report "Finland Neurology Devices Investment Opportunities, Analysis and Forecasts to 2018" to their offering.

This new report by Global Markets Direct provides key market data on the Finland Neurology Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within six market categories - CSF Management, Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices, Neurosurgical Products and Radiosurgery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on key recent developments.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Global Markets Direct's team of industry experts.

Scope:

- Market size and company share data for Neurology Devices market categories - CSF Management, Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices, Neurosurgical Products and Radiosurgery.

- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within six market categories. Data from 2004 to 2011, forecast forward for 7 years to 2018.

- 2011 company shares and distribution shares data for each of the six market categories.

- Global corporate-level profiles of key companies operating within the Finland Neurology Devicesmarket.

- Key players covered include Medtronic, Inc., St. Jude Medical, Inc., Natus Medical Incorporated, Cadwell Laboratories, Inc., Stryker Corporation, B. Braun Melsungen AG and others.

Reasons to Buy:

- Develop business strategies by identifying the key market categories and segments poised for strong growth.

- Develop market-entry and market expansion strategies.

- Design competition strategies by identifying who-stands-where in the Finland Neurology Devices competitive landscape.

- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.

- What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Companies Mentioned:

- Medtronic, Inc.

- St. Jude Medical, Inc.

- Natus Medical Incorporated

- Cadwell Laboratories, Inc.

- Stryker Corporation

- B. Braun Melsungen AG

- DePuy, Inc.

- CareFusion Corporation

- Covidien plc

- Integra LifeSciences Holdings Corporation

- Terumo Corporation

- Nihon Kohden Corporation

- Micromed S.p.A

- Cyberonics, Inc.

- Christoph Miethke GmbH & Co. KG

- Sophysa S.A.

- Boston Scientific Corporation

- KARL STORZ GmbH & Co. KG

For more information visit http://www.researchandmarkets.com/research/j6vkjm/finland_neurology

Source: Global Markets Direct


View the original article here

Research and Markets: Switzerland Nephrology and Urology Devices Investment Opportunities, Analysis and Forecasts to ...

DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/vcjsbd/switzerland_nephro) has announced the addition of Global Markets Direct's new report "Switzerland Nephrology and Urology Devices Investment Opportunities, Analysis and Forecasts to 2018" to their offering.

This new report by Global Markets Direct, provides key market data on the Switzerland Nephrology and Urology Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within three market categories - Incontinence Devices, Lithotripters and Renal Dialysis Equipment. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on key recent developments.

Scope:

- Market size and company share data for Nephrology and Urology Devices market categories - Incontinence Devices, Lithotripters and Renal Dialysis Equipment.

- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within three market categories. Data from 2004 to 2011, forecast forward for 7 years to 2018.

- 2011 company shares and distribution shares data for each of the three market categories.

- Global corporate-level profiles of key companies operating within the Switzerland Nephrology and Urology Devicesmarket.

- Key players covered include Svenska Cellulosa Aktiebolaget SCA, Fresenius Medical Care AG & Co. KGaA, HARTMANN GROUP, Coloplast A/S, Baxter International Inc., ONTEX International N.V. and others.

Reasons to Buy:

- Develop business strategies by identifying the key market categories and segments poised for strong growth.

- Develop market-entry and market expansion strategies.

- Design competition strategies by identifying who-stands-where in the Switzerland Nephrology and Urology Devices competitive landscape.

- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.

- What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Companies Mentioned:

- Svenska Cellulosa Aktiebolaget Sca

- Fresenius Medical Care Ag & Co. Kgaa

- Hartmann Group

- Coloplast A/S

- Baxter International Inc.

- Gambro Ab

- Ontex International N.V.

- First Quality Enterprises, Inc.

- B. Braun Melsungen Ag

- Astra Tech Inc.

- Covidien Plc

- Siemens Healthcare

- Teleflex Incorporated

- Dornier Medtech Gmbh

- Storz Medical Ag

- Medline Industries, Inc.

For more information visit http://www.researchandmarkets.com/research/vcjsbd/switzerland_nephro

Source: Global Markets Direct


View the original article here

Tuesday, June 12, 2012

Research and Markets: Portugal Endoscopy Devices Investment Opportunities, Analysis and Forecasts to 2017

DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/34ppv2/portugal_endoscopy) has announced the addition of Global Markets Direct's new report "Portugal Endoscopy Devices Investment Opportunities, Analysis and Forecasts to 2017" to their offering.

Portugal Endoscopy Devices Investment Opportunities, Analysis and Forecasts to 2017, a new report by Global Markets Direct, provides key market data on the Portugal Endoscopy Devices market.

The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within seven market categories - Capsule Endoscope Systems, Endoscopic Instruments, Endoscopic Reprocessors, Endoscopy Fluid Management Systems, Endoscopy Visualization Systems, Flexible Endoscopes and Rigid Endoscopes.

The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on key recent developments.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Global Markets Direct's team of industry experts.

Scope

- Market size and company share data for seven Endoscopy Devices market categories.

- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within seven market categories. Data from 2003 to 2010, forecast forward for 7 years to 2017.

- 2010 company shares and distribution shares data for each of the seven market categories.

- Global corporate-level profiles of key companies operating within the Portugal Endoscopy Devices market.

Reasons to buy

- Develop business strategies by identifying the key market categories and segments poised for strong growth.

- Develop market-entry and market expansion strategies.

- Design competition strategies by identifying who-stands-where in the Portugal Endoscopy Devices competitive landscape.

- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.

- What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Companies Mentioned

- Advanced Sterilization Products Services

- B. Braun Melsungen AG

- FUJIFILM Holdings Corporation

- Given Imaging

- Hoya Corporation

- IntroMedic

- KARL STORZ GmbH & Co.

- Minntech Corporation

- Olympus Corporation

- Richard Wolf

- Stryker Corporation

For more information visit http://www.researchandmarkets.com/research/34ppv2/portugal_endoscopy

Source: Global Markets Direct


View the original article here

Wednesday, June 6, 2012

Research and Markets: Turkey Neurology Devices Investment Opportunities, Analysis and Forecasts to 2018

DUBLIN--(BUSINESS WIRE)--

Dublin - Research and Markets (http://www.researchandmarkets.com/research/kht27k/turkey_neurology_d) has announced the addition of Global Markets Direct's new report "Turkey Neurology Devices Investment Opportunities, Analysis and Forecasts to 2018" to their offering.

Turkey Neurology Devices Investment Opportunities, Analysis and Forecasts to 2018, a new report by Global Markets Direct, provides key market data on the Turkey Neurology Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within six market categories - CSF Management, Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices, Neurosurgical Products and Radiosurgery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on key recent developments.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Global Markets Direct's team of industry experts.

Scope

- Market size and company share data for Neurology Devices market categories.

- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within six market categories. Data from 2004 to 2011, forecast forward for 7 years to 2018.

- 2011 company shares and distribution shares data for each of the six market categories.

- Global corporate-level profiles of key companies operating within the Turkey Neurology Devices market.

Reasons to buy

- Develop business strategies by identifying the key market categories and segments poised for strong growth.

- Develop market-entry and market expansion strategies.

- Design competition strategies by identifying who-stands-where in the Turkey Neurology Devices competitive landscape.

- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.

- What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Companies Mentioned

- Accuray Incorporated

- B. Braun Melsungen

- Boston Scientific

- Cadwell Laboratories

- CareFusion

- Christoph Miethke GmbH & Co.

- Covidien

- Cyberonics

- DePuy

- Elekta AB

- Integra LifeSciences Holdings

- KARL STORZ GmbH & Co.

- Medtronic

- Micromed

- Natus Medical

- Nihon Kohden

- Sophysa S.A.

- St. Jude Medical

- Stryker

- Terumo

For more information visit http://www.researchandmarkets.com/research/kht27k/turkey_neurology_d

Source: Global Markets Direct


View the original article here

Thursday, May 31, 2012

Research and Markets: Turkey Nephrology and Urology Devices Investment Opportunities, Analysis and Forecasts to 2018

DUBLIN--(BUSINESS WIRE)--

Dublin - Research and Markets (http://www.researchandmarkets.com/research/t9chrs/turkey_nephrology) has announced the addition of Global Markets Direct's new report "Turkey Nephrology and Urology Devices Investment Opportunities, Analysis and Forecasts to 2018" to their offering.

This report provides key market data on the Turkey Nephrology and Urology Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within three market categories - Incontinence Devices, Lithotripters and Renal Dialysis Equipment. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on key recent developments.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Global Markets Direct's team of industry experts.

Scope:

- Market size and company share data for Nephrology and Urology Devices market categories - Incontinence Devices, Lithotripters and Renal Dialysis Equipment.

- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within three market categories. Data from 2004 to 2011, forecast forward for 7 years to 2018.

- 2011 company shares and distribution shares data for each of the three market categories.

- Global corporate-level profiles of key companies operating within the Turkey Nephrology and Urology Devicesmarket.

- Key players covered include Fresenius Medical Care AG & Co. KGaA, Gambro AB, Baxter International Inc., Svenska Cellulosa Aktiebolaget SCA, B. Braun Melsungen AG, HARTMANN GROUP and others.

Reasons to Buy:

- Develop business strategies by identifying the key market categories and segments poised for strong growth.

- Develop market-entry and market expansion strategies.

- Design competition strategies by identifying who-stands-where in the Turkey Nephrology and Urology Devices competitive landscape.

- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.

- What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Key Topics Covered:

1 Table of Contents

2 Introduction

3 Nephrology and Urology Devices In Turkey

4 Incontinence Devices In Turkey

5 Lithotripters In Turkey

6 Renal Dialysis Equipment In Turkey

7 Overview of Key Companies in Turkey Nephrology and Urology Devices Market

List of Tables (44 Total)

List of Figures (36 Total)

For more information visit http://www.researchandmarkets.com/research/t9chrs/turkey_nephrology

Source: Global Markets Direct


View the original article here

Research and Markets: Ireland Neurology Devices Investment Opportunities, Analysis and Forecasts to 2018

DUBLIN--(BUSINESS WIRE)--

Dublin - Research and Markets (http://www.researchandmarkets.com/research/2xdlt9/ireland_neurology) has announced the addition of Global Markets Direct's new report "Ireland Neurology Devices Investment Opportunities, Analysis and Forecasts to 2018" to their offering.

This report provides key market data on the Ireland Neurology Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within five market categories - CSF Management, Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Neurosurgical Products. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on key recent developments.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Global Markets Direct's team of industry experts.

Scope:

- Market size and company share data for Neurology Devices market categories - CSF Management, Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Neurosurgical Products .

- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within five market categories. Data from 2004 to 2011, forecast forward for 7 years to 2018.

- 2011 company shares and distribution shares data for each of the six market categories.

- Global corporate-level profiles of key companies operating within the Ireland Neurology Devicesmarket.

- Key players covered include Medtronic, Inc., St. Jude Medical, Inc., Stryker Corporation, B. Braun Melsungen AG, Covidien plc, DePuy, Inc. and others.

Reasons to Buy:

- Develop business strategies by identifying the key market categories and segments poised for strong growth.

- Develop market-entry and market expansion strategies.

- Design competition strategies by identifying who-stands-where in the Ireland Neurology Devices competitive landscape.

- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.

- What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Key Topics Covered:

1 Table of Contents

2 Introduction

3 Neurology Devices In Ireland

4 CSF Management In Ireland

5 Interventional Neurology In Ireland

6 Neurological Diagnostic Equipment In Ireland

7 Neurostimulation Devices In Ireland

8 Neurosurgical Products In Ireland

9 Overview of Key Companies in Ireland Neurology Devices Market

List of Tables (52 Total)

List of Figures (38 Total)

For more information visit http://www.researchandmarkets.com/research/2xdlt9/ireland_neurology

Source: Global Markets Direct


View the original article here

Saturday, April 7, 2012

'Android being activated on 850,000 devices daily' - Hindustan Times

Google Inc. CEO Larry Page arrives at the Robert F. Peckham Federal Courthouse in San Jose, California. Credit: Reuters/Norbert von der GroebenGoogle Inc's chief executive said the company's fledgling social network, Google+, has scored more than 100 million active users, and he reiterated the Internet search giant's commitment to making long-term bets.

Larry Page, also co-founder who took over the top job from Eric Schmidt in April

2011, said in a 2012 strategy update that the search giant had made progress revamping Google around key business opportunities.

Page said that Google's smartphone operating system, Android, was being activated on 850,000 mobile devices every day.

He signaled Google's intentions to make hardware devices when its $12.5 billion acquisition of Motorola Mobility Holdings closes later this year, even as some observers have speculated that Google was only interested in the company for its extensive patent portfolio.

"We are excited about the opportunities to build great devices capitalizing on the tremendous success and growth of Android and Motorola's long history of technological innovation," Page wrote.

Founded by Page and Sergey Brin in 1998, Google has grown into a corporate behemoth, with roughly $38 billion in revenue last year and nearly $45 billion in cash and securities on its balance sheet as of the end of September of 2011.

While Google has dominated Internet searching for a decade, the company has struggled to find its footing in social networking, with Facebook, Twitter and other start-ups stealing Web traffic and engineering talent.

Since Page took back the reins in April 2011, Google has moved aggressively to make the company a force in the fast-growing social networking market, with the launch of its Google+ social networking service.

"Our goal is long-term growth in revenue and absolute profit—so we invest aggressively in future innovation while tightly managing our short-term costs," Page wrote.

Page did not provide any new financial details in his letter. Google is due to report its first quarter financial results next week.

Google has also faced criticism about some of its privacy practices during Page's tenure. And it has drawn fire over its search rankings system, with some accusing the search company of favoring its own products over rival services.


View the original article here

Sunday, January 22, 2012

Research and Markets: Dry Powder Inhalation: Technology, Devices, Markets and Opportunities

BlackBerry maker's CEOs hand reins to insiderReuters

Research In Motion's Mike Lazaridis and Jim Balsillie have bowed to investor pressure and resigned as co-CEOs, …


View the original article here

Friday, January 6, 2012